We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT03588299
Brief Title: Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle".

First Submitted : July 6, 2018
First Submitted that Met QC Criteria : July 6, 2018
First Posted : July 17, 2018

Last Update Submitted that Met QC Criteria : February 3, 2023
Last Update Posted : February 6, 2023 (Estimate)